Lotus Pharmaceutical Co., Ltd. appointed Mr. Arni Hardarson as Representative of Institutional Director in place of Joel Morales, effective 1 January 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
290 TWD | +0.87% |
|
-0.51% | +6.62% |
13/06 | Lotus Pharmaceutical Co., Ltd. Announces Audit and Remuneration Committee Changes | CI |
13/06 | Lotus Pharmaceutical Co., Ltd. Announces Board Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.62% | 236.27Cr | |
+55.19% | 81TCr | |
+47.26% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.40% | 25TCr | |
+3.64% | 23TCr | |
+12.98% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Change of the Representative of Institutional Director